Scilex Holding Company filed a Form 8-K on November 17, 2026, disclosing that its audit committee dismissed BPM LLP as independent registered public accounting firm on November 11, 2026, and appointed Pipara & Co LLP in its place.
Key Highlights
- Dismissal approved: The audit committee approved the dismissal of BPM LLP on November 11, 2026, with BPM notified on November 16, 2026.
- Going concern paragraphs: BPM's audit reports for fiscal years ended December 31, 2025 and December 31, 2024 each included an explanatory paragraph regarding "substantial doubt about the Company's ability to continue as a going concern."
- No disagreements reported: According to the filing, there were no disagreements with BPM on accounting principles, financial statement disclosure, or auditing scope during the covered periods.
- No reportable events: The filing states no "reportable events," as defined in Item 304(a)(1)(v) of Regulation S-K, occurred during BPM's engagement period.
- New auditor appointed: Pipara & Co LLP was appointed on November 13, 2026, to serve for the quarter and nine months ending September 30, 2026, and the fiscal year ending December 31, 2026.
- Existing relationship: The filing notes that Pipara currently serves as the independent registered public accounting firm of Semnur Pharmaceuticals, Inc., a majority-owned subsidiary of the company.
- BPM letter pending: As of the filing date, BPM had not yet furnished a letter to the SEC stating whether it agrees with the disclosures made in the report.
Scilex Audit Committee Acts on Auditor Change in November 2026
Scilex Holding Company (NASDAQ:SCLX), an emerging growth company headquartered in Palo Alto, California, disclosed a change in its certifying accountant under Item 4.01 of Form 8-K. According to the filing, the company's audit committee approved the dismissal of BPM LLP on November 11, 2026, and the company formally notified BPM of that decision on November 16, 2026.
The filing states that BPM's audit reports for the two most recent fiscal years did not contain an adverse opinion or a disclaimer of opinion and "were not qualified or modified as to uncertainty, audit scope or accounting principles," with one exception: each report included an explanatory paragraph citing substantial doubt about the company's ability to continue as a going concern. The filing further reports that during the fiscal years ended December 31, 2025 and December 31, 2024, and through the date of dismissal, there were no disagreements with BPM and no reportable events as defined under Regulation S-K.
On November 13, 2026, the audit committee appointed Pipara & Co LLP as the company's new independent registered public accounting firm, covering the quarter and nine months ending September 30, 2026, and the full fiscal year ending December 31, 2026. The appointment was subject to completion of customary client acceptance procedures, according to the filing. Pipara already serves as auditor for Semnur Pharmaceuticals, Inc., described in the filing as a majority-owned subsidiary of Scilex. The filing states that prior to this engagement, neither the company nor anyone on its behalf consulted with Pipara on accounting principles, audit opinions, or any matter constituting a disagreement or reportable event, except in connection with Pipara's existing role at Semnur.
What Was Disclosed
Scilex Holding Company disclosed the dismissal of BPM LLP and the appointment of Pipara & Co LLP as its independent registered public accounting firm, effective November 2026, with no disagreements or reportable events cited in connection with the auditor transition.


Please wait processing your request...